GLYCOCONJUGATE JOURNAL

Scope & Guideline

Pioneering Research in Glycoconjugate Science

Introduction

Explore the comprehensive scope of GLYCOCONJUGATE JOURNAL through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore GLYCOCONJUGATE JOURNAL in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0282-0080
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1984 to 2024
AbbreviationGLYCOCONJUGATE J / Glycoconjugate J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The Glycoconjugate Journal focuses on the multifaceted roles of glycoconjugates in biology and medicine, emphasizing their significance in disease mechanisms, therapeutic applications, and biotechnological advancements. The journal aims to provide a platform for innovative research that explores the structural and functional diversity of glycoconjugates, as well as their interactions with various biological systems.
  1. Glycobiology and Disease Mechanisms:
    Research exploring the roles of glycoconjugates in various diseases, including cancer, neurodegeneration, and metabolic disorders, highlighting their potential as biomarkers and therapeutic targets.
  2. Glycoconjugate Synthesis and Characterization:
    Studies focused on the chemical synthesis, enzymatic modifications, and structural characterization of glycoconjugates, providing insights into their functional properties and applications.
  3. Lectin and Glycan Interactions:
    Investigations into the interactions between lectins and glycans, which are crucial for understanding cell signaling, immune responses, and pathogen recognition.
  4. Glycoconjugate Vaccines and Therapeutics:
    Research related to the development of glycoconjugate vaccines and therapeutics, addressing their design, immunogenicity, and clinical applications in infectious diseases and cancer.
  5. Glycan Profiling and Analytical Techniques:
    Advancements in analytical methods for glycan profiling, including mass spectrometry and chromatography, to enhance the understanding of glycosylation patterns in health and disease.
The Glycoconjugate Journal is currently witnessing a rise in interest in several emerging themes, reflecting the dynamic nature of glycobiology and its applications in health and disease. These trends indicate a growing recognition of the importance of glycoconjugates in various biological contexts.
  1. Glycans in Cancer Immunology:
    There is an increasing focus on the role of glycans in cancer immunology, particularly in understanding how glycosylation affects tumor immune evasion and therapy resistance, highlighting glycans as potential targets for immunotherapy.
  2. Therapeutic Applications of Glycans:
    Research exploring the therapeutic applications of glycans, including their use in drug delivery systems and as therapeutic agents, is gaining traction, showcasing the translational potential of glycoconjugate research.
  3. Microbiome-Glycan Interactions:
    Emerging studies are investigating the interactions between gut microbiota and glycans, with implications for understanding metabolic health, immunity, and disease, reflecting a holistic view of glycan functions in human health.
  4. Advanced Glycoconjugate Vaccines:
    The development of novel glycoconjugate vaccines, particularly in response to infectious diseases like COVID-19, is trending, emphasizing the importance of glycoconjugates in vaccine design and immune response.
  5. Glycobiology in Neurodegenerative Diseases:
    Research linking glycobiology to neurodegenerative diseases, including the role of glycans in neuroinflammation and neuroprotection, is emerging as a significant area of interest, underscoring the relevance of glycoconjugates in brain health.

Declining or Waning

While the journal has consistently published impactful research, certain themes appear to be declining in prominence. This shift may reflect evolving research interests within the field of glycobiology and changing technological landscapes.
  1. Traditional Glycobiology Studies:
    There is a noticeable decrease in publications focusing solely on classical glycobiology topics without integrative approaches, as researchers increasingly explore interdisciplinary themes that combine glycobiology with other biological sciences.
  2. Basic Enzymatic Functions of Glycosyltransferases:
    Research dedicated to the basic enzymatic functions of glycosyltransferases seems to be waning, possibly due to a shift towards more applied research that investigates their roles in complex biological systems rather than isolated enzymatic activities.
  3. Static Glycan Structure Analyses:
    Studies that primarily focus on the static structural analysis of glycans without functional or dynamic context are becoming less frequent, indicating a trend towards understanding glycan behavior in live systems.
  4. Glycoconjugates in Non-Medical Applications:
    Research on glycoconjugates in areas outside of medical applications, such as agriculture or environmental studies, appears to be less frequent, which may reflect a narrowing of the journal's focus towards health-related research.

Similar Journals

JOURNAL OF CELLULAR PHYSIOLOGY

Connecting Basic Biology with Clinical Innovations
Publisher: WILEYISSN: 0021-9541Frequency: 12 issues/year

JOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.

TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY

Exploring the Frontiers of Glycoscience and Glycotechnology
Publisher: GAKUSHIN PUBL COISSN: 0915-7352Frequency: 7 issues/year

TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, a reputable journal published by GAKUSHIN PUBL CO, serves as an essential resource for researchers and professionals engaged in the evolving fields of glycoscience and glyotechnology. Established in 1989, this journal has progressively focused on stimulating discussions and disseminating pivotal findings that impact various applications in biochemistry and organic chemistry. With an impressive converge covering decades up to 2024, the journal has carved a niche within the scientific community, despite currently being classified in the lower quartiles (Q4) for its respective categories in 2023. This designation underscores the potential for growth and enhanced visibility within research networks. While it currently operates under a subscription-based model, TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY remains committed to fostering innovation and interdisciplinary collaboration, providing a critical platform for the exploration of glycan structures and functions. Located in Tokyo, Japan, the journal invites contributions that contribute to the future direction of glycoscientific research and its applications.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Illuminating Pathways in Experimental Research
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

GLYCOBIOLOGY

Connecting Biochemistry and Health through Glycans
Publisher: OXFORD UNIV PRESS INCISSN: 0959-6658Frequency: 12 issues/year

GLYCOBIOLOGY is a premier journal published by Oxford University Press Inc., focusing on the multidisciplinary field of glycoscience. With an ISSN of 0959-6658 and an E-ISSN of 1460-2423, this journal has established itself as an essential resource for researchers, professionals, and students interested in the biochemical aspects of glycan structures, functions, and interactions. The journal boasts a Q1 rank in the biochemistry category for 2023, placing it in the top-tier of scholarly publications, and achieving a percentile rank of 71st out of 438 in the Scopus database for biochemistry, genetics, and molecular biology. Covering integral aspects of glycobiology since its inception in 1990, GLYCOBIOLOGY offers a robust platform for the dissemination of novel research findings, reviews, and methodologies that advance the understanding of glycan-related processes and their implications in health and disease. Researchers can access high-quality content that not only promotes scientific discourse but also pushes the boundaries of knowledge in this vital field.

EMBO REPORTS

Advancing Molecular Biology Through Rigorous Research
Publisher: WILEYISSN: 1469-221XFrequency: 12 issues/year

EMBO REPORTS, published by WILEY, is a premier journal in the fields of Biochemistry, Genetics, and Molecular Biology, recognized for its rigorous peer-review process and impactful scientific contributions. Established in the year 2000 in the United Kingdom, this journal has maintained a stellar reputation, reflected in its consistent positioning within the Q1 category across these disciplines as of 2023. EMBO REPORTS excels in disseminating high-quality and timely research that addresses fundamental questions and challenges in molecular biology and genetics, making it an invaluable resource for researchers, professionals, and students. With impressive Scopus rankings, including Genetics at the 32nd rank and a 90th percentile placement, it fosters an environment for scholarly exchange and advances in knowledge. While Open Access options are not available, the journal continues to enhance its impact through traditional subscription models, thereby maintaining wide visibility in the scientific community. Its ongoing evolution promises continued relevance and influence until at least 2024.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Exploring the molecular mechanisms that shape our world.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Cell Discovery

Empowering Open Access to Cutting-Edge Research
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

BIOLOGY OF THE CELL

Fostering dialogue in the dynamic field of cell biology.
Publisher: WILEYISSN: 0248-4900Frequency: 12 issues/year

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

BIOSCIENCE REPORTS

Advancing the Frontiers of Life Sciences
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology

Unveiling the Complexities of Cellular Mechanisms
Publisher: PLEIADES PUBLISHING INCISSN: 1990-7478Frequency: 4 issues/year

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.